Log in using OpenID

Immunoglobulin Market Size Will Escalate Rapidly in the Near Future

Increasing application of immunoglobulin is gaining significant traction among pharmaceutical and Biopharmaceuticals Company for the research and development of immunoglobulin.
Immunoglobulin Market Size, Share,
Review, Outlook, Future Analysis And
Synthesis By 2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to
particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as
antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody
immune response is highly complex and very specific. The various immunoglobulin classes and subclasses
(isotypes) differ in their biological features, structure, target specificity and distribution. Hence, the
assessment of the immunoglobulin isotype can provide useful insight into complex humoral immune
response. There are different classes of immunoglobulin such as IgG, IgA, and IgM, which are used for
the treatment of various immunological and neurological diseases. These immunoglobulins can be
administered intravenously and subcutaneously.
Download PDF Brochure of This Business Report at
Immunoglobulin Market Dynamics
Furthermore, increasing application of immunoglobulin is gaining significant traction among
pharmaceutical and Biopharmaceuticals Company for the research and development of immunoglobulin.
Moreover, increasing number of intravenous product approvals and clinical trials for new clinical
applications is anticipated to provide potential growth opportunities to the industry. For instance, in May
2018, ADMA Biologics, Inc. announced that the company had received U.S. patent for treating
respiratory infection. The patent consist of usage of polyclonal immunoglobulin preparation for treatment
of respiratory infection, where the issued patent extends to January 2035.
Kedrioin Biopharma and Kamada Ltd. together in May 2018, launched two human-derived
protein therapeutics companies announced that KEDRAB [Rabies Immune Globulin (Human)] has
been launched in the U.S. as it has received U.S. Food and Drug Administration approval for
passive, transient post-exposure prophylaxis of rabies infection, when given immediately after
contact with a rabid or possibly rabid animal and concurrent with the rabies vaccine. Such
advancement and launches in field of immunoglobulin are expected to foster growth of the
immunoglobulin market in near future.
Report includes chapters which deeply display the following deliverable about industry :
• Immunoglobulin Market Research Objective and Assumption
• Immunoglobulin Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Immunoglobulin Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Immunoglobulin Market, By Regions
• Immunoglobulin Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Immunoglobulin Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Immunoglobulin Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Immunoglobulin Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region
• Research Findings and Conclusion
Immunoglobulin Market - Regional Insights
Geographically, global Immunoglobulin market is segmented into North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa. North America accounted for the largest share in the
immunoglobulin market, followed by Europe in 2016. This is attributed to increasing number of the U.S.
Food and Drug Administration approval for immunoglobulin. For instance, in 2016, Shire plc. announced
the launch of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] the first and only
Subcutaneous 20% treatment option without proline available in the U.S. to treat adult and pediatric
patients (two years of age and older) with primary immunodeficiency (PI).
Immunoglobulin Market - Competitive Analysis
The major players operating in the market include Baxter international Inc., CSL Ltd., Grifols S.A,
Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI
Pharma Inc., and Bayer Healthcare. Other players in the immunoglobulin market include Hualan
Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood
Products Co., Ltd., Option Care Enterprises, Inc., ADMA Biologics, Inc., and BioScrip, Inc.
Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called
PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing
trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps
biotechnology and pharmaceutical companies to analyze the market trend, competition, and market
potential. For more information or to access this database, kindly click on the below link or contact at
[email protected]
Grab Best Discount on This Business Report at
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Poul Master
Poul Master241   document Email
Health and Medicine
File Size
345 KB
immunoglobulin, Immunoglobulin Market
Report inappropriate content